Zydus’ biopharma arm acquires global proprietary rights for Progeria treatment

AHMEDABAD: Sentynl Therapeutics Inc (Sentynl), a US-based biopharmaceutical company wholly owned by Ahmedabad-headquartered Zydus Lifesciences, recently completed the acquisition of global proprietary rights More...